The coronavirus pandemic has inspired unprecedented collective action to address urgent concerns, such as health and food security, and multinational companies working in these areas are uniquely positioned to help to meet local needs.
Bayer, a global enterprise with core competencies in the life science fields of health care and agriculture, is contributing to the fight against the coronavirus through its products and expertise in health and nutrition – with actions spanning the globe, says Dr. Shurjeel Choudhri, senior vice-president and head of Medical and Scientific Affairs at Bayer Canada.
“There has been a lot of activity since the pandemic started,” explains Dr. Choudhri, who leads a working group that is actively looking to identify areas where Bayer can support the Canadian health care system, physicians and patients. “In addition to committing funding to a number of research efforts, we are donating personal protective equipment and medication for clinical trials where our products have shown to have potential benefit.”
Mitigation measures vary from region to region. In Italy, one of the regions with significant impact from COVID-19, Bayer’s medical experts joined their colleagues in treating patients on the front line, says Dr. Choudhri.
In Canada, Bayer’s support has included outreach to professional societies, for example, the Canadian Cardiovascular Society, the Canadian Ophthalmological Society and the Society of Obstetricians and Gynaecologists of Canada, to help them inform their members about the different aspects of COVID-19.
“We have also donated protective equipment, so that health care providers like ophthalmologists and gynaecologists can continue to safely see their patients,” he says. “And we are actively working to support innovations that can provide solutions for what we call the ‘new normal’ – the way forward as more and more activities resume after the lockdown.”
Produced by Randall Anthony Communications. The Globe’s editorial department was not involved in its creation.